logo
episode-header-image
Feb 2025
57m 40s

Virtual Cell Models, Tahoe-100 and Data ...

Conviction
About this episode
tail spinning
Up next
Today
Building an Autonomous Enterprise for Real-World Services with Netic Founder Melisa Tokmak
When your AC fails in a heatwave, you don’t want a busy signal; you need a solution. Netic founder and CEO Melisa Tokmak joins host Elad Gil to explain how Netic’s autonomous AI platform acts as an intermediary between companies and customers, deploying agents to instantly handle ... Show More
34m 29s
Jul 23
Building an Autonomous Delivery Experience with DoorDash Co-Founders Andy Fang and Stanley Tang
DoorDash is not just a delivery company. From its inception, co-founders Andy Fang and Stanley Tang operated it as a robotics and autonomy company. Andy and Stanley join Sarah Guo to explain how autonomous tech and AI are reshaping consumer habits, commerce, and delivery. Andy an ... Show More
49m 19s
Jul 9
Travel Through the Lens of AI with with Booking.com CEO Glenn Fogel
When Glenn Fogel joined Priceline in 2000, the business was worth a few hundred million dollars. One week later, the Nasdaq peaked, eventually sending its stock down to a dollar a share. But over 25 years later, Booking Holdings has scaled over 1000x into an over $100 billion dol ... Show More
41m 4s
Recommended Episodes
Sep 2025
Faster Science, Better Drugs
<p>Can we make science as fast as software? </p><p>In this episode, Erik Torenberg talks with Patrick Hsu (cofounder of Arc Institute) and a16z general partner Jorge Conde about Arc’s “virtual cells” moonshot, which uses foundation models to simulate biology and guide experiments ... Show More
56m 26s
Sep 2025
From AlphaFold to MMseqs2-GPU: How AI is Accelerating Protein Science - Ep. 273
Listen as two leading researchers at the cutting edge of computational biology explore breakthrough GPU accelerations that are changing how we understand life's molecular machinery. Chris Dallago, Research Lead at NVIDIA and Visiting Professor at Duke University, and Martin Stein ... Show More
34m 37s
Oct 2025
How CytoReason is Bridging the Data Insight Gap to Accelerate Healthcare Breakthroughs - Ep. 276
Shai Shen-Orr, co-founder and chief scientist at CytoReason and professor at the Technion, talks about the next frontier in healthcare: disease modeling. Shai shares how CytoReason bridges the gap between exploding biological data and actionable insight, powering smarter, faster ... Show More
35m 12s
Aug 2024
Recursion CEO Chris Gibson on Accelerating the Biopharmaceutical Industry With AI - Ep. 230
Techbio is a field combining data, technology and biology to enhance scientific processes — and AI has the potential to supercharge the biopharmaceutical industry further. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Chris Gibson, cofounder and CEO of Rec ... Show More
37m 55s
Apr 2025
Isomorphic Labs Discusses AI-Driven Drug Discovery and the Future of Medicine - Ep. 252
Max Jaderberg and Sergei Yakneen from Isomorphic Labs discuss how AI is enhancing drug discovery by treating biology as an information processing system. They share how advanced AI models like AlphaFold 3 are accelerating the pipeline and paving the way for a future of precision ... Show More
39m 25s
Sep 2023
AI Revolution: Digital Biology with insitro's Daphne Koller
Daphne Koller is the founder and CEO of insitro, a company using AI and machine learning to engineer drug discovery. In this conversation with a16z's Vijay Pande, she discusses how an LLM for cells could revolutionize drug discovery and how to bridge the technological and cultura ... Show More
22m 28s
Jul 2025
Startup Valuations, Biotech's Crunch & AI's Massive TAM | E2147
Today's show: It's another blockbuster panel of insiders, as Alex sits down with Astasia Myers from Felicis, Matt Turck from First Mark Capital, and D.A. Wallach of Time BioVentures. AI is reshaping early-stage investing, with startups raising record-setting rounds adn chasing $1 ... Show More
1h 16m
Feb 2024
Moderna and Drug Discovery With AI
Vaccine-maker Moderna is also a data company, and that’s enabling it to use AI to drastically reduce drug-development times, Chief Information Officer Brad Miller tells Bloomberg Intelligence’s Sam Fazeli and Mandeep Singh. This episode of the Tech Disruptors podcast looks at a w ... Show More
36m 35s
Oct 2025
Google’s AI Breakthrough in Cancer, Protein Powders Exposed | Marc Benioff, Eiso Kant, Dante Vaisbort, Alice Bentinck, Eric Seufert, Pim de Witte
(01:17) - Google’s AI Breakthrough in Cancer (22:44) - 𝕏 Timeline Reactions (30:37) - Protein Powders Exposed (35:41) - 𝕏 Timeline Reactions (01:36:03) - Dante Vaisbort, a University of Chicago graduate and co-founder of Albacore Inc., discusses his company's development of Gho ... Show More
3h 15m
May 2024
GSK’s Use of AI in Vaccine Tech, Drug Discovery
GSK’s Chief Digital and Technology Officer Shobie Ramakrishnan discusses how the company is leveraging AI and data models for vaccine development and drug discovery in this episode of Bloomberg Intelligence’s Tech Disruptors podcast. BI’s Health-Care Analyst Sam Fazeli and Techno ... Show More
42m 42s